Skip to main content
. 2024 Mar 18;14:6499. doi: 10.1038/s41598-024-57062-6

Table 2.

Characteristics of Patients.

No Gender Age Duration of TS (year) Newly diagnosed cases Comorbid disorder Family history of TD Family history of other neurodevelopmental and psychiatric disorders YGTSS Medications
Total motor scores (0–25) Total phonic scores (0–25) Impairment scores (0–50)
C1 Boy 6 1.2 No No No No 11 4 10 Tiapride
C2 Boy 10 2.5 No No Yes No 15 6 10 Clonidine
C3 Girl 6 2.2 No No No No 8 8 0 Tiapride
C4 Boy 11 5.0 No No No No 10 14 20 Tiapride
C5 Girl 4 1.0 Yes No No No 9 12 0 Clonidine
C6 Boy 11 5.0 No No No No 10 10 10 Tiapride
C7 Boy 11 2.5 No Yes, ADHD No No 10 14 20 Tiapride + Clonidine
C8 Boy 7 2.4 No No No No 6 10 10 Tiapride
C9 Girl 5 1.0 Yes No No No 12 8 0 Tiapride
C10 Boy 8 1.8 No No No No 11 10 10 Tiapride
C11 Boy 5 2.5 No No No No 7 12 10 Tiapride
C12 Boy 7 2.0 No Yes, ADHD No No 13 8 10 Tiapride + Clonidine
C13 Boy 10 1.5 No No No Yes 10 12 10 Tiapride